Anti GGH pAb (ATL-HPA025226)

Atlas Antibodies

Catalog No.: ATL-HPA025226-25

Protein Description: gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
Gene Name: GGH
Alternative Gene Name:
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000073987: 77%, ENSRNOG00000007351: 73%
Entrez Gene ID: 8836
Uniprot ID: Q92820
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications

• Application: WB, IHC
• Reactivity: Human
• Clonality: Polyclonal
• Host: Rabbit
• Immunogen: FDDGDYFPVWGTCLGFEELSLLISGECLLTATDTVDVAMPLNFTGGQLHSRMFQNFPTELLLSLAVEPLTANFHKWSLSVKNFTMNEKLKK
• Gene Sequence: FDDGDYFPVWGTCLGFEELSLLISGECLLTATDTVDVAMPLNFTGGQLHSRMFQNFPTELLLSLAVEPLTANFHKWSLSVKNFTMNEKLKK
• Gene ID - Mouse: ENSMUSG00000073987
• Gene ID - Rat: ENSRNOG00000007351
• Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Citations for Anti GGH pAb (ATL-HPA025226) – 3 Found

Melling, Nathaniel; Rashed, Masoud; Schroeder, Cornelia; Hube-Magg, Claudia; Kluth, Martina; Lang, Dagmar; Simon, Ronald; Möller-Koop, Christina; Steurer, Stefan; Sauter, Guido; Jacobsen, Frank; Büscheck, Franziska; Wittmer, Corinna; Clauditz, Till; Krech, Till; Tsourlakis, Maria Christina; Minner, Sarah; Huland, Hartwig; Graefen, Markus; Budäus, Lars; Thederan, Imke; Salomon, Georg; Schlomm, Thorsten; Wilczak, Waldemar. High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer. International Journal Of Molecular Sciences. 2017;18(2) 

Bertolo, Alessandro; Baur, Martin; Guerrero, Julien; Pötzel, Tobias; Stoyanov, Jivko. Autofluorescence is a Reliable in vitro Marker of Cellular Senescence in Human Mesenchymal Stromal Cells. Scientific Reports. 2019;9(1):2074. 

Shubbar, Emman; Helou, Khalil; Kovács, Anikó; Nemes, Szilárd; Hajizadeh, Shahin; Enerbäck, Charlotta; Einbeigi, Zakaria. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. Bmc Cancer. 2013;13( 23374458):47.